-
Early FDA Approval Speculation Sends AcelRX Pharma Shares Soaring
Monday, October 2, 2017 - 3:55pmAcelRx Pharmaceuticals Inc (NASDAQ: ACRX) shares have been on a tear and are trading near a two-year high after speculation started doing the rounds that its pain treatment candidate DSUVIA is poised to get early approval. About 3.25 million shares exchanged hands, roughly 2.5 times the average...
Read More >> -
6 Dividend-Trap Stocks That Could Follow Mattel And GNC's Lead, Cutting Or Suspending Payouts
Friday, July 14, 2017 - 1:39pmLiving beyond means is always a risky proposition, be it an individual or a business. When companies are cash-constrained, the first thing they will lay their hands on would be dividends, as these are not mandatory payments stipulated by corporate law. An investor who is lured by the lucre of an...
Read More >> -
If The Economy Is Improving, Why Are Dollar Stores The Only Retailers With Positive Trends?
Friday, June 23, 2017 - 12:35pmThe retail sector per se is in the doldrums, fighting more than one foe - fundamental flaws, a behemoth that is steam rolling over their prospects and a see-sawing economy. The retail sector has been bleeding jobs for four straight months now. Earnings reports of retailers are speaking volumes...
Read More >> -
Tesaro Is A Top Rumor Mill Stock Right Now; Here Is A Timeline Of The Chatter
Tuesday, June 13, 2017 - 12:24pmTESARO Inc (NASDAQ: TSRO) takeover rumors have been swirling around since September 2016, and Benzinga continues to hear M&A chatter Tuesday. The biopharmaceutical company has been a huge acquisition target, as biotech companies look to gain access to Zejula, an approved inhibitor to treat...
Read More >> -
Neurotrope Denies Involvement In Paying For Promotional Articles
Wednesday, May 3, 2017 - 4:20pmOn Wednesday, TheStreet biotech reporter Adam Feuerstein raised alarm that an unknown source paid to convert Seeking Alpha posts about Neurotrope Inc (NASDAQ: NTRP) into unofficial promotional pieces for bryostatin, the company's lead drug candidate. Neurotrope denied any involvement. "The...
Read More >> -
The 'Irrational Exuberance' Of 1996, And How You'll Know It Has Returned
Tuesday, April 11, 2017 - 9:02am"Irrational Exuberance," the phrase made popular by former Fed Chairman Alan Greenspan has come to haunt the markets once more. The markets have been on an extended rally, in place since the economy exited the Great Recession in 2009. Rampaging Bull Officially, the recession ended in...
Read More >> -
Cardiovascular Players Could Be Eyeing Esperion
Monday, April 10, 2017 - 11:53amTakeover chatter prompted a 5.5 percent spike in Esperion Therapeutics Inc (NASDAQ: ESPR) Monday. A source familiar with the matter told Benzinga the cholesterol-focused pharmaceutical could be drawing interest from a player in the cardiovascular space. The reaction follows a Friday Seeking Alpha...
Read More >> -
SCOTUS Discusses Facebook, Twitter As Constitutional Rights
Tuesday, February 28, 2017 - 4:08pmThe U.S. Supreme Court debated Monday whether access to social media is guaranteed under the First Amendment. The points contributed to the case of a North Carolina law barring registered sex offenders from such sites. Throughout the session, the justices considered the merits and importance of...
Read More >> -
Cemtrex Plummets 30% On Critical Seeking Alpha Post; Company Calls Claims 'Malicious'
Wednesday, February 22, 2017 - 4:53pmCemtrex Inc (NASDAQ: CETX) shares plunged more than 33 percent Wednesday after a Seeking Alpha user published a report that said “all signs point to deception and failure.” The author, a self-described activist investor named Richard Pearson, delineated corporate activity he deemed...
Read More >> -
Another Short Thesis On Mallinckrodt Just Surfaced
Monday, February 6, 2017 - 3:19pmMallinckrodt PLC (NYSE: MNK), a developer of branded and generic specialty pharmaceutical products and therapies, is a popular stock among short sellers. Back in January, Martin Shkreli explained to Benzinga why a Federal Trade Commission lawsuit against the company is justified. Prior to that,...
Read More >>